Tower Research Capital (TRC)’s DaVita DVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $619K | Buy |
4,028
+3,209
| +392% | +$435K | 0.02% | 776 |
|
|
2025
Q4 | $93K | Sell |
819
-2,924
| -78% | -$356K | ﹤0.01% | 1991 |
|
|
2025
Q3 | $497K | Buy |
3,743
+1,589
| +74% | +$218K | 0.01% | 864 |
|
|
2025
Q2 | $307K | Buy |
2,154
+531
| +33% | +$75.2K | 0.01% | 1404 |
|
|
2025
Q1 | $248K | Sell |
1,623
-2,276
| -58% | -$358K | 0.01% | 1245 |
|
|
2024
Q4 | $583K | Sell |
3,899
-313
| -7% | -$49.1K | 0.01% | 954 |
|
|
2024
Q3 | $690K | Buy |
4,212
+898
| +27% | +$133K | 0.02% | 694 |
|
|
2024
Q2 | $459K | Buy |
3,314
+2,624
| +380% | +$362K | 0.01% | 1422 |
|
|
2024
Q1 | $95.3K | Sell |
690
-5,490
| -89% | -$659K | ﹤0.01% | 1849 |
|
|
2023
Q4 | $647K | Sell |
6,180
-6,320
| -51% | -$584K | 0.01% | 1177 |
|
|
2023
Q3 | $1.18M | Buy |
12,500
+9,908
| +382% | +$1.01M | 0.04% | 471 |
|
|
2023
Q2 | $260K | Buy |
2,592
+1,979
| +323% | +$184K | 0.01% | 1379 |
|
|
2023
Q1 | $50K | Sell |
613
-985
| -62% | -$78.9K | ﹤0.01% | 2492 |
|
|
2022
Q4 | $119K | Sell |
1,598
-8,951
| -85% | -$695K | ﹤0.01% | 1691 |
|
|
2022
Q3 | $873K | Sell |
10,549
-186
| -2% | -$16.3K | 0.01% | 763 |
|
|
2022
Q2 | $858K | Sell |
10,735
-19,452
| -64% | -$1.97M | 0.02% | 796 |
|
|
2022
Q1 | $3.41M | Buy |
30,187
+25,030
| +485% | +$2.81M | 0.03% | 416 |
|
|
2021
Q4 | $587K | Buy |
5,157
+230
| +5% | +$24.7K | 0.01% | 1005 |
|
|
2021
Q3 | $573K | Sell |
4,927
-11,882
| -71% | -$1.49M | 0.01% | 886 |
|
|
2021
Q2 | $2.02M | Buy |
16,809
+3,288
| +24% | +$389K | 0.05% | 301 |
|
|
2021
Q1 | $1.46M | Buy |
13,521
+12,481
| +1,200% | +$1.39M | 0.02% | 593 |
|
|
2020
Q4 | $122K | Sell |
1,040
-486
| -32% | -$49.5K | ﹤0.01% | 2159 |
|
|
2020
Q3 | $130K | Buy |
1,526
+422
| +38% | +$36.1K | ﹤0.01% | 2928 |
|
|
2020
Q2 | $87K | Buy |
1,104
+765
| +226% | +$59.7K | ﹤0.01% | 2583 |
|
|
2020
Q1 | $26K | Sell |
339
-1,006
| -75% | -$79.1K | ﹤0.01% | 1588 |
|
|
2019
Q4 | $101K | Sell |
1,345
-1,611
| -54% | -$107K | 0.01% | 932 |
|
|
2019
Q3 | $169K | Sell |
2,956
-6,714
| -69% | -$390K | 0.01% | 1087 |
|
|
2019
Q2 | $544K | Buy |
9,670
+4,166
| +76% | +$216K | 0.04% | 439 |
|
|
2019
Q1 | $299K | Buy |
5,504
+3,677
| +201% | +$204K | 0.02% | 937 |
|
|
2018
Q4 | $94K | Sell |
1,827
-2,540
| -58% | -$163K | 0.01% | 977 |
|
|
2018
Q3 | $313K | Sell |
4,367
-3,377
| -44% | -$239K | 0.02% | 736 |
|
|
2018
Q2 | $538K | Buy |
+7,744
| New | +$517K | 0.03% | 609 |
|
|
2018
Q1 | – | Sell |
-17
| Closed | -$1K | – | 3372 |
|
|
2017
Q4 | $1K | Buy |
+17
| New | +$1.05K | ﹤0.01% | 3332 |
|
|
2017
Q2 | – | Sell |
-8,486
| Closed | -$577K | – | 2863 |
|
|
2017
Q1 | $577K | Buy |
8,486
+5,766
| +212% | +$382K | 0.06% | 122 |
|
|
2016
Q4 | $174K | Sell |
2,720
-268
| -9% | -$16.7K | 0.02% | 688 |
|
|
2016
Q3 | $197K | Buy |
2,988
+1,084
| +57% | +$76.3K | 0.02% | 492 |
|
|
2016
Q2 | $147K | Buy |
+1,904
| New | +$144K | 0.01% | 865 |
|
|
2015
Q2 | – | Sell |
-2,479
| Closed | -$201K | – | 4504 |
|
|
2015
Q1 | $201K | Buy |
+2,479
| New | +$190K | 0.02% | 408 |
|
|
2014
Q4 | – | Sell |
-8,732
| Closed | -$657K | – | 4138 |
|
|
2014
Q3 | $638K | Buy |
8,732
+7,972
| +1,049% | +$584K | 0.07% | 209 |
|
|
2014
Q2 | $55K | Buy |
760
+334
| +78% | +$23.2K | 0.01% | 1236 |
|
|
2014
Q1 | $29K | Sell |
426
-52
| -11% | -$3.46K | ﹤0.01% | 1530 |
|
|
2013
Q4 | $30K | Sell |
478
-106
| -18% | -$6.22K | 0.01% | 1880 |
|
|
2013
Q3 | $33K | Buy |
584
+572
| +4,767% | +$32.8K | ﹤0.01% | 2275 |
|
|
2013
Q2 | $1K | Buy |
+12
| New | +$749 | ﹤0.01% | 3666 |
|
Other funds holding DVA
VCM
VPM
Tower Research Capital (TRC)'s DVA Position: Q1 2026 in Review
Tower Research Capital (TRC) increased its DaVita (DVA) stake by 392% in Q1 2026, buying an estimated $435K and bringing the position to 4,028 shares worth $619K. The position accounts for 0.02% of the portfolio, ranked #776.
Tower Research Capital (TRC) first reported a position in DVA in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.41M in Q1 2022. 582 funds tracked by Wall St. Rank hold DVA as of Q1 2026.
- Tower Research Capital (TRC) held 4,028 shares of DaVita worth $619K as of Q1 2026.
- Tower Research Capital (TRC) bought 3,209 DaVita shares in Q1 2026, an estimated $435K.
- DaVita made up 0.02% of Tower Research Capital (TRC)'s portfolio in Q1 2026, its #776 holding.
- Tower Research Capital (TRC) first reported a position in DaVita in Q2 2013 and has held it in 44 quarters since.
- Tower Research Capital (TRC)'s DaVita position peaked at $3.41M in Q1 2022.
- 582 funds tracked by Wall St. Rank held DaVita as of Q1 2026.
Based on Tower Research Capital (TRC)'s 13F filing for Q1 2026, filed 15 May 2026.